• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

左手踝部伴有 IDH1 R132C 突变的巨大软骨肉瘤的马富奇综合征：病例报告。

Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report.

机构信息

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, 150 Ximen Road, Linhai, 317000, Zhejiang, China.

DIAN Diagnostics, Hangzhou, 310058, Zhejiang, China.

出版信息

World J Surg Oncol. 2022 Jun 29;20(1):218. doi: 10.1186/s12957-022-02686-z.

DOI:10.1186/s12957-022-02686-z
PMID:35765075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9241289/
Abstract

BACKGROUND

Maffucci syndrome (MS) is a rare, nonhereditary congenital mesodermal dysplasia characterized by multiple enchondromas and hemangiomas, associated with an increased risk of developing malignant tumors. Given their rarity, the pathogenesis of these tumors has not been clarified, and there is no standard treatment.

CASE PRESENTATION

We present a case of a 45-year-old man with MS to supplement the clinical manifestations and explore the molecular mechanism of MS. The patient underwent amputation surgery to inhibit tumor development and was diagnosed with MS with 1-2 grade giant chondrosarcoma in the left ankle. In addition, the whole exon analysis results revealed isocitrate dehydrogenase 1 (IDH1) R132C mutation in chondrosarcoma lesions but not in blood DNA.

CONCLUSIONS

This case report showed MS complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation, which is appropriate to monitor the development of MS pathology and other concomitant lesions.

摘要

背景

马富奇综合征（MS）是一种罕见的非遗传性先天性中胚层发育不良，其特征为多发性软骨瘤和血管瘤，并伴有恶性肿瘤发生风险增加。由于这些肿瘤较为罕见，其发病机制尚未阐明，也没有标准的治疗方法。

病例介绍

我们报告了一例 45 岁男性 MS 病例，以补充临床表现并探讨 MS 的分子机制。该患者接受了截肢手术以抑制肿瘤发展，并被诊断为左踝部 1-2 级巨大软骨肉瘤合并 MS。此外，全外显子分析结果显示软骨肉瘤病变中存在异柠檬酸脱氢酶 1（IDH1）R132C 突变，但在血液 DNA 中未发现。

结论

本病例报告显示 MS 合并左踝部巨大软骨肉瘤，并存在 IDH1 R132C 突变，适合监测 MS 病理和其他伴随病变的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/c9a711b6f88d/12957_2022_2686_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/ba21ecd642b8/12957_2022_2686_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/cb3330198b9a/12957_2022_2686_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/02e5ca62fe55/12957_2022_2686_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/c9a711b6f88d/12957_2022_2686_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/ba21ecd642b8/12957_2022_2686_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/cb3330198b9a/12957_2022_2686_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/02e5ca62fe55/12957_2022_2686_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eef/9241289/c9a711b6f88d/12957_2022_2686_Fig4_HTML.jpg

相似文献

1
Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report.左手踝部伴有 IDH1 R132C 突变的巨大软骨肉瘤的马富奇综合征：病例报告。
World J Surg Oncol. 2022 Jun 29;20(1):218. doi: 10.1186/s12957-022-02686-z.
2
Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.马富西综合征患者垂体腺瘤中的体细胞异柠檬酸脱氢酶1（IDH1）突变
J Neurosurg. 2016 Jun;124(6):1562-7. doi: 10.3171/2015.4.JNS15191. Epub 2015 Oct 16.
3
Maffucci syndrome complicated by three different central nervous system tumors sharing an IDH1 R132C mutation: case report.Maffucci 综合征并发三种不同的中枢神经系统肿瘤，均携带 IDH1 R132C 突变：病例报告。
J Neurosurg. 2018 Dec 21;131(6):1829-1834. doi: 10.3171/2018.6.JNS18729. Print 2019 Dec 1.
4
A Rare Co-Occurrence of Maffucci Syndrome and Astrocytoma with IDH1 R132H Mutation: A Case Report.Maffucci 综合征合并 IDH1 R132H 突变星形细胞瘤：一例报告
Medicina (Kaunas). 2023 May 31;59(6):1056. doi: 10.3390/medicina59061056.
5
IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci's Syndrome.IDH1 R132C 和 ERC2 L309I 突变有助于马富奇综合征的发展。
Front Endocrinol (Lausanne). 2021 Nov 1;12:763349. doi: 10.3389/fendo.2021.763349. eCollection 2021.
6
Chondrosarcoma of the nasal cavity in a patient with Maffucci syndrome: case report and review of the literature.马富西综合征患者鼻腔软骨肉瘤：病例报告及文献复习
World J Surg Oncol. 2014 Dec 17;12:387. doi: 10.1186/1477-7819-12-387.
7
Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.1例马富西综合征患者中与杯状急性髓系白血病相关的IDH1和NPM1体细胞镶嵌突变
Int J Hematol. 2015 Dec;102(6):723-8. doi: 10.1007/s12185-015-1892-z. Epub 2015 Oct 27.
8
A case of Maffucci syndrome with a buccal hemangioma harboring a mutation in IDH1.一例伴有口腔血管瘤的 Maffucci 综合征，该血管瘤存在 IDH1 突变。
Oral Oncol. 2021 Nov;122:105553. doi: 10.1016/j.oraloncology.2021.105553. Epub 2021 Oct 6.
9
[Synchronous primary double: condrosarcoma and sarcoma high grade fusocelular associated with Maffucci syndrome].[同步原发性双发：软骨肉瘤与高级别梭形细胞肉瘤伴马富西综合征]
Acta Ortop Mex. 2019 Sep-Oct;33(5):325-328.
10
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.体细胞镶嵌性 IDH1 和 IDH2 突变与 Ollier 病和 Maffucci 综合征中的软骨瘤和梭形细胞血管瘤有关。
Nat Genet. 2011 Nov 6;43(12):1256-61. doi: 10.1038/ng.1004.

引用本文的文献

1
Vascular Tumors Unraveling a Rare Genetic Disorder.血管肿瘤：揭开一种罕见遗传病之谜
Indian Dermatol Online J. 2025 Apr 15;16(3):531-532. doi: 10.4103/idoj.idoj_1287_24. eCollection 2025 May-Jun.
2
Genetic and Functional Changes in Mitochondria in the Pituitary Adenoma: The Pathogenesis and Its Therapy.垂体腺瘤中线粒体的遗传与功能变化：发病机制及其治疗
Antioxidants (Basel). 2024 Dec 11;13(12):1514. doi: 10.3390/antiox13121514.
3
A rare presentation of Maffucci syndrome: A case report and literature review.马富西综合征的罕见表现：一例病例报告及文献综述

本文引用的文献

1
Somatic variant (p.R132C) in an adult male with Maffucci syndrome.成年男性马富奇综合征伴体细胞变异（p.R132C）。
Cold Spring Harb Mol Case Stud. 2021 Dec 9;7(6). doi: 10.1101/mcs.a006127. Print 2021 Dec.
2
Natural history of Ollier disease and Maffucci syndrome: Patient survey and review of clinical literature.奥里耶病和马富西综合征的自然病史：患者调查和临床文献复习。
Am J Med Genet A. 2020 May;182(5):1093-1103. doi: 10.1002/ajmg.a.61530. Epub 2020 Mar 7.
3
Successful treatment of spindle cell hemangiomas in a patient with Maffucci syndrome and review of literatures.
Exp Ther Med. 2023 Jul 25;26(3):435. doi: 10.3892/etm.2023.12134. eCollection 2023 Sep.
4
Disastrous evolution of ollier disease: a rare case report.骨软骨瘤病的灾难性演变：一例罕见病例报告。
Ann Med Surg (Lond). 2023 May 17;85(6):2985-2989. doi: 10.1097/MS9.0000000000000678. eCollection 2023 Jun.
成功治疗一名马富奇综合征患者的梭形细胞血管瘤，并复习文献。
Dermatol Ther. 2019 May;32(3):e12919. doi: 10.1111/dth.12919. Epub 2019 Apr 29.
4
Unsatisfactory response to sirolimus in Maffucci syndrome-associated spindle cell hemangiomas.马富奇综合征相关性梭形细胞血管瘤应用西罗莫司治疗效果不佳。
Dermatol Ther. 2019 May;32(3):e12851. doi: 10.1111/dth.12851. Epub 2019 Feb 20.
5
Maffucci syndrome complicated by three different central nervous system tumors sharing an IDH1 R132C mutation: case report.Maffucci 综合征并发三种不同的中枢神经系统肿瘤，均携带 IDH1 R132C 突变：病例报告。
J Neurosurg. 2018 Dec 21;131(6):1829-1834. doi: 10.3171/2018.6.JNS18729. Print 2019 Dec 1.
6
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.AG-120（艾伏尼布）的发现：一种用于治疗异柠檬酸脱氢酶1（IDH1）突变癌症的首创突变型IDH1抑制剂。
ACS Med Chem Lett. 2018 Jan 19;9(4):300-305. doi: 10.1021/acsmedchemlett.7b00421. eCollection 2018 Apr 12.
7
The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.代谢酶在间叶性肿瘤和肿瘤综合征中的作用：遗传学、病理学和分子机制。
Lab Invest. 2018 Apr;98(4):414-426. doi: 10.1038/s41374-017-0003-6. Epub 2018 Jan 16.
8
Genomic Classification and Prognosis in Acute Myeloid Leukemia.急性髓系白血病的基因组分类与预后
N Engl J Med. 2016 Jun 9;374(23):2209-2221. doi: 10.1056/NEJMoa1516192.
9
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.CNVkit：通过靶向DNA测序进行全基因组拷贝数检测与可视化
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873. doi: 10.1371/journal.pcbi.1004873. eCollection 2016 Apr.
10
IDH mutations in cancer and progress toward development of targeted therapeutics.癌症中的异柠檬酸脱氢酶（IDH）突变与靶向治疗药物研发进展
Ann Oncol. 2016 Apr;27(4):599-608. doi: 10.1093/annonc/mdw013.